Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$30.46 - $46.04 $6,944 - $10,497
228 Added 2.72%
8,599 $250,000
Q2 2023

Jul 31, 2023

SELL
$31.57 - $37.73 $95,530 - $114,170
-3,026 Reduced 26.55%
8,371 $359,000
Q1 2023

May 12, 2023

BUY
$29.72 - $41.45 $54,447 - $75,936
1,832 Added 19.15%
11,397 $364,000
Q4 2022

Jan 19, 2023

BUY
$30.23 - $38.71 $27,207 - $34,839
900 Added 10.39%
9,565 $341,000
Q3 2022

Nov 01, 2022

BUY
$22.51 - $38.27 $195,049 - $331,609
8,665 New
8,665 $252,000
Q2 2022

Jul 29, 2022

SELL
$20.97 - $37.47 $155,765 - $278,327
-7,428 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$34.38 - $65.77 $61,884 - $118,386
1,800 Added 31.98%
7,428 $274,000
Q4 2021

Jan 10, 2022

BUY
$63.78 - $97.86 $358,953 - $550,756
5,628 New
5,628 $397,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.